A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk KUALA LUMPUR, Malaysia, Sept. 13, 2024 /PRNewswire/ -- GlaxoSmithKline Pharmaceutical ...

A vaccine for the prevention of shingles in adults aged 50 and over and those aged 18 and over at increased risk (from left to right) Dr Alap Gandhi, Country Medical Director of GSK Malaysia and ...

Researchers conducted an observational study to compare the risk for dementia associated with both the live and recombinant shingles vaccines. The recombinant herpes zoster (shingles) vaccine is ...

reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine). Shingrix is approved to prevent shingles (herpes zoster) in adults ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK has turned to Brooke Shields to get the message out about shingles vaccination. The drugmaker has worked with the model and actor to talk to female celebrities and patients aged 50 years and ...

The P.E.I. government has lowered the age requirement for a free shingles vaccine to 50. The change from age 60 was announced in a news release Monday morning and is effective immediately.

Credit: GSK KUALA LUMPUR, Sept 10 (Bernama) -- GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced the launch of the Herpes Zoster (HZ) vaccine, Shingrix, also known as Recombinant Zoster ...